Stock Events

Stock Events

Dexcom 

$84.16
553
-$4.25-4.81%Friday 08:26

Statistics

Day High
84.44
Day Low
84.16
52W High
88.68
52W Low
58.64
Volume
3,586
Avg. Volume
-
Mkt Cap
31.39B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 11Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.47
0.55
0.64
0.73
Expected EPS
0.7151
Actual EPS
N/A

Financials

17.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.66BRevenue
836.3MNet Income

Analyst Ratings

$93.83Average Price Target
The highest estimate is ⁦120.00⁩.
From 18 ratings within the last 6 months. This is not an investment recommendation.
Buy
94%
Hold
6%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXCM.BOATS. It's not an investment recommendation.
NVIDIA
143
NVDA
Amazon
136
AMZN
Apple
129
AAPL
Microsoft
123
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap10.38B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap502.83M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap115.96B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap58B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Show More
CEO
ISIN
US2521311074

Listings

STU
DE
DC4.STU
MI
IT
1DXCM.MI
XETRA
DE
DC4.XETRA
MU
DE
DC4.MU

0 Comments

Share your thoughts

FAQs

What is Dexcom stock price today?▼
The current price of DXCM.BOATS is $84.16 USD — it has decreased by -4.81% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Dexcom stocks are traded under the ticker DXCM.BOATS.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 31.39B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on February 11, 2027.
What were Dexcom earnings last quarter?▼
DXCM.BOATS earnings for the last quarter are 0.73 USD per share, whereas the estimation was 0.67 USD resulting in a +8.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 4.66B USD.
What is Dexcom net income for the last year?▼
DXCM.BOATS net income for the last year is 836.3M USD.
In which sector is Dexcom located?▼
Dexcom operates in the Other sector.
When did Dexcom complete a stock split?▼
The last stock split for Dexcom was on June 13, 2022 with a ratio of 4:1.